In Market Pathways, NESTcc SVP Sandra Siami discusses real-world evidence, COVID-19, and new initiatives at NESTcc

NESTcc Senior Vice President Sandra Siami was interviewed in a feature article in the July-August 2020 issue of MedTech Strategist Market Pathways.

In her interview, Ms. Siami covers NESTcc’s role in expanding the use of real-world evidence (RWE) across the medical device ecosystem and the value NESTcc can offer: quality evidence by design. She also touches on how the COVID-19 pandemic has highlighted the importance of utilizing RWE and how NESTcc’s RWE Test-Case projects underscore the need for cross-collaboration between ecosystem stakeholders to achieve common goals. In closing, Ms. Siami outlines NESTcc’s future state, including her vision for becoming adaptable to changes in the landscape like COVID-19, and new work on the horizon such as active surveillance capabilities.

Read the full article, “Keeping MedTech Real-World Evidence Real.”